Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant disorder caused by pathogenic variants in the RB1 gene, characterized by an increased risk of retinoblastoma in early childhood. Individuals with hereditary retinoblastoma also have an increased risk of developing secondary cancers, such as osteosarcoma, melanoma and carcinomas in childhood and adulthood.
Features include sometimes findings: Vitritis. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 1 | Cleft palate |
Bones and joints | 1 | Osteosarcoma |
Eyes | 1 | Retinal calcification |
Blood and immune system | 1 | Lymphoma |
Retinoblastoma. The most common presenting sign is a white pupillary reflex (leukocoria). Strabismus is the second most common presenting sign and may accompany or precede leukocoria . Unusual presenting signs include glaucoma, orbital cellulitis, uveitis, hyphema, or vitreous hemorrhage. Most affected children are diagnosed before age five years. Atypical manifestations are more frequent in older children. Probands with retinoblastoma usually present in one of the following clinical settings:
Source: GeneReviews — "Retinoblastoma"
RB1 function has not been fully characterized.
Hereditary retinoblastoma is associated with mutations in the RB1 gene on chromosome 13.
Guidelines for diagnosis and care of children and families affected by retinoblastoma have been published .
Retinoblastoma should be suspected in children with any of the following:
Leukocoria (white pupil)
Strabismus
Change in eye appearance
Reduced visual acuity
should be suspected in an individual with any of the following:
Diagnosis of retinoblastoma, including unilateral (unifocal and multifocal) and bilateral involvement
Retinoma
Family history of retinoblastoma
The diagnosis of retinoblastoma is established in a proband by retinal examination with full pupillary dilatation by an ophthalmologist or optometrist. Confirmation of the diagnosis and determination of the disease extent is accomplished by examination under anes...
Source: GeneReviews — "Retinoblastoma"
Several hereditary ocular conditions of childhood can clinically simulate retinoblastoma:
NDP-related persistent fetal vasculature and NDP-related Coats disease (See NDP-Related Retinopathies.)
• Tuberous sclerosis complex
Norrie disease (See NDP-Related Retinopathies.)
• Incontinentia pigmenti
Familial exudative vitreoretinopathy (See Phenotypic Series: Exudative Vitreoretinopathy.)
• Von Hippel-Lindau syndrome
Ocular infestation by Toxocara canis can also clinically simulate retinoblastoma.
Source: GeneReviews — "Retinoblastoma"
Genetic testing for RB1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hereditary retinoblastoma has been reported in the published literature.
No approved treatments are currently available for hereditary retinoblastoma. The disease remains an area of unmet medical need.
Guidelines for retinoblastoma care have been developed (see and Kenya National Retinoblastoma Strategy Best Practice Guidelines).
To establish the extent of disease and needs in an individual diagnosed with retinoblastoma, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Source: GeneReviews — "Retinoblastoma"
1 trial found
Guidelines for clinical screening for children at risk have been published . Further information regarding medical surveillance for those who have had or are at risk of developing retinoblastoma is available in the guidelines for retinoblastoma care. Children who have undergone successful treatment require frequent follow-up examination for early detection of newly arising intraocular tumors, as indicated in the guidelines.
Table 3.
Retinoblastoma: Recommended Surveillance for Individuals at Risk and Affected Individuals
System/Concern | Evaluation | Frequency
| • Eye exam under anesthesia (in young children)
Clinical eye exams w/o anesthesia once children are cooperative w/exam
| • Every 3-4 wks until age 6 mos
Every 2 mos from age 6 mos-3 yrs
Every 3-6 mos from age 3-7 yrs
Annually from age 7-10 yrs
Every 2 yrs from age 10 yrs
Prompt clinical investigation of any signs/symptoms of subsequent non-ocular malignant neoplasms1 | Ongoing education of affected persons caregivers w/clinical investigation as needed
| • Clinical eye exam (w/o anesthesia)
Eye ultrasound
| • Every 3-6 mos from diagnosis to 7 yrs
Every 2 yrs from age 7 yrs
| • Retinal exams
Photographic imaging to detect any change early
| Every 1-2 yrs
| Prompt clinical investigation of any signs/symptoms of malignant neoplasms1 |
Source: GeneReviews — "Retinoblastoma"
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
27 publications have been identified in PubMed for hereditary retinoblastoma. Research spans Case Report / Case Series (46%), Epidemiology / Natural History (23%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 46% |
Disease patterns and progression | 6 | 23% |
Testing and diagnosis research | 4 | 15% |
Research summaries | 3 | 12% |
Laboratory research | 1 | 4% |
Bhola DE (2026). [PMID: 42011192](https://pubmed.ncbi.nlm.nih.gov/42011192/). *Cureus*. [Case Report / Case Series]
Yadav A (2026). [PMID: 41313398](https://pubmed.ncbi.nlm.nih.gov/41313398/). *Indian journal of pediatrics*. [Case Report / Case Series]
Dersch AM (2026). [PMID: 41667398](https://pubmed.ncbi.nlm.nih.gov/41667398/). *Ophthalmic genetics*. [Diagnostic / Biomarker]
Abbott J (2026). [PMID: 41697179](https://pubmed.ncbi.nlm.nih.gov/41697179/). *Ophthalmology*. [Review / Meta-Analysis]
Andoh JE (2026). [PMID: 42027623](https://pubmed.ncbi.nlm.nih.gov/42027623/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Zhao W (2026). [PMID: 41949209](https://pubmed.ncbi.nlm.nih.gov/41949209/). *Genes Chromosomes Cancer*. [Case Report / Case Series]
Ford J (2026). [PMID: 42240833](https://pubmed.ncbi.nlm.nih.gov/42240833/). *Pediatr Radiol*. [Diagnostic / Biomarker]
Shimshon HK (2025). [PMID: 39969487](https://pubmed.ncbi.nlm.nih.gov/39969487/). *Journal of pediatric ophthalmology and strabismus*. [Case Report / Case Series]
Toki H (2025). [PMID: 40569505](https://pubmed.ncbi.nlm.nih.gov/40569505/). *Bulletin of mathematical biology*. [Basic Science / Preclinical]
Walker JK (2025). [PMID: 39663399](https://pubmed.ncbi.nlm.nih.gov/39663399/). *Eye (London, England)*. [Epidemiology / Natural History]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning hereditary retinoblastoma
Updated Sep 7, 2026
A retrospective cohort study compares Cox proportional hazards regression and multiple logistic regression models to identify mortality factors in children with retinoblastoma in Malaysia. The findings may inform future research and treatment strategies for this rare pediatric cancer.
A new study utilizes a machine learning pipeline to analyze global sentiment regarding treatment hesitancy in retinoblastoma. This observational infodemiology research highlights factors influencing patient decisions and could inform future treatment strategies.
A new study discusses the management of spontaneous scleral rupture in an infant with bilateral retinoblastoma, highlighting the complexities of treating this aggressive cancer. The findings may inform future clinical approaches to similar cases.